Category & trade
Primary
pharmaceutical-drugs · embed-ft 0.62
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Tech stack
AI readiness
AI-Readiness score
44 / 100 · partial · see similar
AI training policy
allowed
Terms of Service
found · https://www.ucb-usa.com/Legal
AI-bot protection
AI files
Compliance (GEO / GDPR)
TLD
Overview
Title
ZILBRYSQ® For Treatment Of Generalized Myasthenia Gravis
Description
ZILBRYSQ® (zilucoplan) Injection is the first FDA-approved self-administered complement C5 inhibitor for the treatment of adult patients with anti-AChR Ab+ gMG.
Final URL
Language
en (html)
Scanned at
2026-07-14 19:44:12